Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Cancers|January 8, 2023
Current State of Immunotherapy and Mechanisms of Immune Evasion in Ewing Sarcoma and OsteosarcomaValentina Evdokimova, Hendrik Gassmann, Laszlo Radvanyi, et al.
Anticancer Research|June 17, 2009
Cleavage of the Ewing tumour-specific EWSR1-FLI1 mRNA by hammerhead ribozymesRegina Hühn, Martin S Staege, Manuela Hesse, et al.
Molecular and Cellular Pediatrics|September 2, 2018
Precision medicine in pediatric oncologyStefan E G Burdach, Mike-Andrew Westhoff, Maximilian Felix Steinhauser, et al.
Cancer Research|November 19, 2004
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targetsMartin S Staege, Christoph Hutter, Ingo Neumann, et al.
Cancers|November 26, 2022
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive TransferBusheng Xue, Kristina von Heyking, Hendrik Gassmann, et al.
Oncotarget|June 2, 2018
Donor lymphocyte infusions in adolescents and young adults for control of advanced pediatric sarcomaSebastian J Schober, Irene von Luettichau, Angela Wawer, et al.
Cells|July 3, 2020
MHC Class I-Restricted TCR-Transgenic CD4+ T Cells Against STEAP1 Mediate Local Tumor Control of Ewing Sarcoma In VivoSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Cells|August 27, 2021
Ewing Sarcoma-Derived Extracellular Vesicles Impair Dendritic Cell Maturation and FunctionHendrik Gassmann, Kira Schneider, Valentina Evdokimova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing SarcomaSebastian Johannes Schober, Caroline Schoening, Jennifer Eck, et al.
Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.
Pageof 2